Cingulate Inc. Debt Instrument, Face Amount
Cingulate Inc. (CING) had Debt Instrument, Face Amount of $3.00 million as of 2023-09-30, per its 10-Q filed 2023-11-13.
Financial Statements › Notes
us-gaap:DebtInstrumentFaceAmount · last filed 2025-03-27
- 2023-09-30: Debt Instrument, Face Amount $3.00M.
- 2023-06-30: Debt Instrument, Face Amount $8.00M.
- 2023-05-31: Debt Instrument, Face Amount $8.00M.
- 2023-05-09: Debt Instrument, Face Amount $8.00M.
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2023-09-30 | $3.00M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $8.00M 10-Q · filed 2023-08-14 |
| 2023-05-31 | $8.00M 10-K · filed 2025-03-27 |
| 2023-05-09 | $8.00M 10-Q · filed 2023-11-13 |
| 2022-12-31 | $5.00M 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |